...
首页> 外文期刊>World Journal of Gastroenterology >Naturally occurring mutations in the reverse transcriptase region of hepatitis B virus polymerase from treatment-na?ve Korean patients infected with genotype C2
【24h】

Naturally occurring mutations in the reverse transcriptase region of hepatitis B virus polymerase from treatment-na?ve Korean patients infected with genotype C2

机译:初治韩国患者感染基因型C2的乙型肝炎病毒聚合酶逆转录酶区域中的自然突变

获取原文

摘要

AIMTo report naturally occurring mutations in the reverse transcriptase region (RT) of hepatitis B virus (HBV) polymerase from treatment na?ve Korean chronic patients infected with genotype C2. METHODSHere, full-length HBV reverse transcriptase RT sequences were amplified and sequenced from 131 treatment na?ve Korean patients chronically infected with hepatitis B genotype C2. The patients had two distinct clinical statuses: 59 patients with chronic hepatitis (CH) and 72 patients with hepatocellular carcinoma (HCC). The deduced amino acids (AAs) at 42 previously reported potential nucleos(t)ide analog resistance (NAr) mutation positions in the RT region were analyzed. RESULTSPotential NAr mutations involving 24 positions were found in 79 of the 131 patients (60.3%). Notably, AA substitutions at 2 positions (rt184 and rt204) involved in primary drug resistance and at 2 positions (rt80 and rt180) that functioned as secondary/compensatory mutations were detected in 10 patients (1 CH patient and 9 HCC patients) and 7 patients (1 CH and 6 HCC patients), respectively. The overall mutation frequencies in the HCC patients (3.17%, 96/3024 mutations) were significantly higher than the frequencies in the CH patients (2.09%, 52/2478 mutations) (P = 0.003). In addition, a total of 3 NAr positions, rt80, rt139 and rt204 were found to be significantly related to HCC from treatment na?ve Korean patients. CONCLUSIONOur data showed that naturally occurring NAr mutations in South Korea might contribute to liver disease progression (particularly HCC generation) in chronic patients with genotype C2 infections.
机译:目的报道治疗天真的韩国慢性病患者感染C2基因型的乙型肝炎病毒(HBV)聚合酶逆转录酶区域(RT)的自然突变。方法从131名慢性乙型肝炎C2型感染天真的韩国患者中扩增并测序全长HBV逆转录酶RT序列。这些患者具有两种不同的临床状态:59例慢性肝炎(CH)和72例肝细胞癌(HCC)。分析了42个先前报道的在RT区域中潜在的核苷酸(t)核苷酸类似物抗性(NAr)突变位置的推导氨基酸(AAs)。结果在131例患者中有79例发现了潜在的NAr突变,涉及24个位置(60.3%)。值得注意的是,在10例患者(1例CH患者和9例HCC患者)和7例患者中检测到了与原发性耐药有关的2个位置(rt184和rt204)以及在2个位置(rt80和rt180)具有继发性/代偿性突变的AA替代。 (1名CH和6名HCC患者)。 HCC患者的总体突变频率(3.17%,96/3024突变)显着高于CH患者的频率(2.09%,52/2478突变)(P = 0.003)。此外,还发现来自天真的韩国患者的总共3个NAr位置,rt80,rt139和rt204与HCC显着相关。结论我们的数据表明,韩国自然发生的NAr突变可能与基因型C2感染的慢性患者的肝脏疾病进展(尤其是HCC产生)有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号